Peter Natesan Pushparaj
-
- Natural Antidiabetic Agents Studies 6
- Immunology top 5%
- IL-33, ST2, and ILC Pathways 6
- Pharmacology top 2%
- Reproductive Medicine top 5%
- Sperm and Testicular Function 17
-
- Asthma and respiratory diseases 10
-
- Reproductive Biology and Fertility 9
-
- Genetic factors in colorectal cancer 7
-
- Colorectal Cancer Treatments and Studies 6
-
- Advanced biosensing and bioanalysis techniques 6
- Co-authors
- J. ManikandanC.H. TanB.K.H. TanKalamegam GauthamanMahmood RasoolDinesh Kumar SrinivasanBenny Kwong Huat TanChee Hong Tan
- Journals
- Frontiers in Pharmacology (6 papers)Saudi Journal of Biological Sciences (5 papers)The World Journal of Men s Health (4 papers)
- Partner nations
- Saudi ArabiaUnited StatesUnited Kingdom
In The Last Decade
Peter Natesan Pushparaj
132 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Complementary and alternative medicine 310
- Endocrinology, Diabetes and Metabolism 534
- Immunology 639
- Pharmacology 261
- Reproductive Medicine 245
Countries citing papers authored by Peter Natesan Pushparaj
This map shows the geographic impact of Peter Natesan Pushparaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Natesan Pushparaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Natesan Pushparaj more than expected).
Fields of papers citing papers by Peter Natesan Pushparaj
This network shows the impact of papers produced by Peter Natesan Pushparaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Natesan Pushparaj. The network helps show where Peter Natesan Pushparaj may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Natesan Pushparaj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 61 | |
| 8 | 2023 | 14 | |
| 9 | 2023 | 0 | |
| 10 | 2023 | 3 | |
| 11 | 2022 | 2 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 6 | |
| 14 | 2020 | 4 | |
| 15 | 2020 | 15 | |
| 16 | 2019 | 29 | |
| 17 | 2019 | 2 | |
| 18 | Evaluation of antimicrobial activity of ethanolic extracts of Azadirachta indica and Psidium guajava against clinically important bacteria at varying pH and temperature | 2017 | 8 |
| 19 | 2012 | 116 | |
| 20 | 2010 | 99 |
About Peter Natesan Pushparaj
Peter Natesan Pushparaj is a scholar working on Reproductive Medicine, Immunology and Immunology and Allergy, having authored 140 papers that have together received 4.0k indexed citations. Recurring topics across this work include Sperm and Testicular Function (17 papers), Asthma and respiratory diseases (10 papers), Reproductive Biology and Fertility (9 papers), Genetic factors in colorectal cancer (7 papers), Natural Antidiabetic Agents Studies (6 papers), IL-33, ST2, and ILC Pathways (6 papers), Colorectal Cancer Treatments and Studies (6 papers) and Advanced biosensing and bioanalysis techniques (6 papers). The work is most often cited by research in Complementary and alternative medicine (310 citations), Endocrinology, Diabetes and Metabolism (534 citations) and Immunology (639 citations). Peter Natesan Pushparaj has collaborated with scholars based in Saudi Arabia, United States and United Kingdom. Frequent co-authors include J. Manikandan, C.H. Tan, B.K.H. Tan, Kalamegam Gauthaman, Mahmood Rasool, Dinesh Kumar Srinivasan, Benny Kwong Huat Tan, Chee Hong Tan, Ashok Agarwal and Alirio J. Melendez. Their work appears in journals such as Frontiers in Pharmacology, Saudi Journal of Biological Sciences, The World Journal of Men s Health, Frontiers in Cell and Developmental Biology and CNS & Neurological Disorders - Drug Targets.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.